Reportlinker Adds Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry

Dec 09, 2010, 13:44 ET from Reportlinker

NEW YORK, Dec. 9, 2010 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry


Pharmaceutical companies are expanding into the Asia-Pacific region to increase their market share and reduce costs. The life sciences industry is difficult enough for technology vendors to enter, but add to it the complexity of emerging markets, and the process can be downright overwhelming. Ovum provides an Introduction to the life sciences in APAC in order for vendors to penetrate the market.

Features and benefits

Offers an overview of the pharmaceutical and biotechnology sectors in Australia, China, India, and Japan

Discusses key areas where there is greatest need for technology in the APAC life sciences industry

Provides go-to-market strategies to help vendors enter the APAC pharma and biotech markets and realize successful


Before attempting to penetrate the APAC pharma market, it is important to understand the complexity of the global life sciences industry. Once vendors understand the industry as a whole, they will better comprehend the dynamics of the APAC markets and how the developed and emerging pharma industries fit into their customers' global strategies.

The Asia-Pacific life sciences industry varies greatly, comprised of both developed and emerging markets. It is also home to small, emerging biotech companies with up to ten employees as well as Big Pharma with thousands of employees. As wide as the spectrum is for size and type of life sciences company, so is the need for IT solutions.

The emerging markets have seen tremendous growth, and this trend will likely continue, but not without the help of key IT solutions. The APAC pharma and biotech sectors are much more open to the use of IT that their Western counterparts, but it is still important for technology vendors to understand where and how to best realize success.

Your key questions answered

Understand the pharmaceutical and biotechnology product lifecycle and business processes

Identify emerging areas of concern for pharmaceutical and biotechnology companies, particularly in Australia, China, India and Japan

Gain insight into what solutions and services will appeal most to APAC life sciences companies



Catalyst 1

Ovum view 2

Key messages 3

Understanding the Pharma Process 8

About the industry 8

The drug discovery and development process is long and expensive 9

The biggest challenge facing the pharma industry is the successful navigation of the 2011 patent cliff 16

The APAC Life Sciences Market 19

Overview of APAC markets 19

Australia's pharmaceutical market 20

China's pharmaceutical market 21

India's pharmaceutical market 23

Japan's pharmaceutical market 25

Slowing growth in major developed markets drives pharma M&A in APAC 26

Trends within countries based on the process areas 27

Opportunities for Technology Vendors 32

How best to capitalize 32

The pharma product lifecycle plays a crucial role in IT strategy 32

IT engagement with pharma comes with its own set of dynamics 42

With no two life sciences markets exactly the same, neither is their IT investment 48

Recommendations for Technology Vendors 53

The right solutions for the right processes 53

Position technology along the pharma lifecycle 53

Know the pharma company's product pipeline and drug portfolio 54

Route to market will be a critical success factor 54

Keep in mind that IT budget allocation does not equal priority 55

Focus on IT solutions that enable the shift towards biotech research 56


Definitions 57

Further reading 58

Methodology 59

Ovum authors 61

Datamonitor author 61

Ovum Consulting 62

Disclaimer 62



Figure 1: The drug discovery and development lifecycle 9

Figure 2: The drug discovery and pre-clinical research processes 10

Figure 3: The clinical trials process 11

Figure 4: SCOR: Capturing the pharma manufacturing process 13

Figure 5: Stakeholders involved in pharma sales and marketing 14

Figure 6: The sales and marketing process through shelf-time 16

Figure 7: Loss in sales due to generic erosion from brands expiring between 2010 and 2014 17

Figure 8: Heat map of discovery and pre-clinical research activity in APAC 28

Figure 9: Heat map of clinical trial activity in APAC 29

Figure 10: Heat map of manufacturing activity in APAC 30

Figure 11: Heat map of sales and marketing activity in APAC 31

Figure 12: The pharma business processes and associated IT solutions 33

Figure 13: Heat map of research IT adoption in APAC over five years 35

Figure 14: Heat map of clinical research IT adoption in APAC over five years 36

Figure 15: Heat map of manufacturing IT adoption in APAC over five years 38

Figure 16: Heat map of sales and marketing IT adoption in APAC over five years 41

Figure 17: Percentage of IT budget allocated to various technology solutions 42

Figure 18: Pharma IT budget allocations by technology category 44

Figure 19: Cloud computing adoption plans in pharma companies 46

Figure 20: Influence of C-level executives on IT investment 47

Figure 21: Australia's IT spending by life sciences sector, 2009-2015 49

Figure 22: China's IT spending by life sciences sector, 2009-2015 50

Figure 23: India's IT spending by life sciences sector, 2009-2015 51

Figure 24: Japan's IT spending by life sciences sector, 2009-2015 52

Figure 25: Priority of technology solution for IT budget allocation 55



Table 1: Pharmaceutical and biotechnology industry sub-segments 8

Table 2: Key population, healthcare expenditure and pharmaceutical and biotechnology market indicators for APAC 19

Table 3: Sales growth for the leading pharmaceutical and biotechnology companies in APAC, 2005–9 20

To order this report:

Healthcare Industry: Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry

Healthcare Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!


Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker